Molecular therapeutics - Lessons from the role of Src in cellular signalling

Folia Biologica

Volumn 51, Issue 4, 2005, Pages 114-120

  Tuháčková, Zdena ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

c Src; Malignant transformation; Signal transduction; Src family kinases; Therapy; v Src

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTINEOPLASTIC AGENT; AP 23451; BOSUTINIB; CELL SURFACE RECEPTOR; CGP 77675; G PROTEIN COUPLED RECEPTOR; GEFITINIB; PD 162531; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STEROID RECEPTOR; SU 11333; UNCLASSIFIED DRUG; [4 [2 CYCLOPENTYL 9 (3 HYDROXYPHENETHYL)PURIN 6 YLAMINO]PHENYL]DIMETHYLPHOSPHINE OXIDE;

CARCINOGENESIS; CELL GROWTH; CLINICAL TRIAL; DISEASE COURSE; DRUG TARGETING; ENZYME ACTIVITY; GENE ACTIVITY; HUMAN; IN VITRO STUDY; LUNG SMALL CELL CANCER; METASTASIS; NONHUMAN; NONVIRAL GENE THERAPY; ONCOGENE SRC; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 24944550952     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Bjorge, J. D., Jakymiw, A., Fujita, D. J. (2000) Selected glimpses into the activation and function of Src kinase. Oncogene 19, 5620-5635.
2. Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L., Courtneidge, S. A. (2000) SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell Biol. 20, 9018-9027.
3. Blume-Jensen, P., Hunter, T. (2001) Oncogenic kinase signalling. Nature 411, 355-365.
4. Boggon, T. J., Eck, M. J. (2004) Structure and regulation of Src family kinases. Oncogene 23, 7918-7927.
5. Boonyaratanakornkit, V., Scott, M. P., Ribon, V., Sherman, L., Anderson, S. M., Maller, J. L., Miller, W. T., Edwards, D. P. (2001) Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8, 269-280.
6. Brábek, J., Constancio, S. S., Shin, N. Y., Pozzi, A., Weaver, A. M., Hanks, S. K. (2004) CAS promotes invasiveness of Src-transformed cells. Oncogene 23, 406-415.
7. Bromann, P. A., Korkaya, H., Courtneidge, S. A. (2004) The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23, 7957-7968.
8. Cabodi, S., Moro, L., Baj, G., Smeriglio, M., Di Stefano, P., Gippone, S., Surico, N., Silengo, L., Turco, E., Tarone, G., Defilippi, P. (2004) p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell. Sci. 117, 1603-1611.
9. Carrera, A. C. (2004) TOR signaling in mammals. J. Cell. Sci. 117, 4615-4616.
10. Clapper, M. L., Coudry, J., Chang, W. C. (2004) beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention. Mutat. Res. 555, 97-105.
11. src. Mol. Cell. Biol. 4, 973-977.
12. De Benedetti, A., Harris, A. L. (1999) eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31, 59-72.
13. Dufner, A., Thomas, G. (1999) Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100-109.
14. Fan, G., Shumay, E., Malbon, C. C., Wang, H. (2001) c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization. J. Biol. Chem. 276, 13240-13247.
15. Frame, M. C. (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 1602, 114-130.
16. Frame, M. C., Fincham, V. J., Carragher, N. O., Wyke, J. A. (2002) v-Src's hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3, 233-245.
17. Gambacorti-Passerini, C. (2004) Oncogenic tyrosine kinases. Cell. Mol. Life Sci. 61, 2895-2896.
18. Goi, T., Shipitsin, M., Lu, Z., Foster, D. A., Klinz, S. G., Feig, L. A. (2000) An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. EMBO J. 19, 623-630.
19. Golubovskaya, V. M., Gross, S., Kaur, A. S., Wilson, R. I., Xu, L. H., Yang, X. H., Cance, W. G. (2003) Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. 1, 755-764.
20. Hakak, Y., Hsu, Y. S., Martin, G. S. (2000) Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene 19, 3164-3171.
21. Hidalgo, M., Rowinsky, E. K. (2000) The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19, 6680-6686.
22. Holland, E. C., Sonenberg, N., Pandolfi, P. P., Thomas, G. (2004) Signaling control of mRNA translation in cancer pathogenesis. Oncogene 23, 3138-3144.
23. Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., Yeatman, T. J. (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21, 187-190.
24. Kazansky, A. V., Rosen, J. M. (2001) Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Cell Growth Differ. 12, 1-7.
25. Lange, C. A. (2004) Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol. Endocrinol. 18, 269-278.
26. 2-. J. Biol. Chem. 279, 48692-48701.
27. Luttrell, D. K., Luttrell, L. M. (2004) Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23, 7969-7978.
28. Ma, Y. C., Huang, X. Y. (2002) Novel regulation and function of Src tyrosine kinase. Cell. Mol. Life Sci. 59, 456-462.
29. Martin, G. S. (2004) The road to Src. Oncogene 23, 7910-7917.
30. Matsumoto, T., Kiguchi, K., Jiang, J., Carbajal, S., Ruffino, L., Beltrán, L., Wang, X. J., Roop, D. R., DiGiovanni, J. (2004) Development of transgenic mice inducibly express an active form of c-Src in the epidermis. Mol. Carcinog. 40, 189-200.
31. McLean, G. W., Fincham, V. J., Frame, M. C. (2000) v-Src induces tyrosine phosphorylation of focal adhesion kinase independently of tyrosine 397 and formation of a complex with Src. J. Biol. Chem. 275, 23333-23339.
32. Odajima, J., Matsumura, I., Sonoyama, J., Daino, H., Kawasaki, A., Tanaka, H., Inohara, N., Kitamura, T., Downward, J., Nakajima, K., Hirano, T., Kanakura, Y. (2000) Full oncogenic activities of v-Src are mediated by multiple signaling pathways. Ras as an essential mediator for cell survival. J. Biol. Chem. 275, 24096-24105.
33. Owens, D. W., McLean, G. W., Wyke, A. W., Paraskeva, C., Parkinson, E. K., Frame, M. C., Brunton, V. G. (2000) The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol. Biol. Cell 11, 51-64.
34. Pawson, T. (2004) Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116, 191-203.
35. Penuel, E., Martin, G. S. (1999) Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol. Biol. Cell 10, 1693-1703.
36. Reynolds, A. B., Roczniak-Ferguson, A. (2004) Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 23, 7947-7956.
37. Roche, S., Koegl, M., Barone, M. V., Roussel, M. F., Courtneidge, S. A. (1995) DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol. Cell Biol. 15, 1102-1109.
38. Roskoski, R., Jr. (2004) Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 324, 1155-1164.
39. Ruggero, D., Pandolfi, P. P. (2003) Does the ribosome translate cancer? Nat. Rev. Cancer 3, 179-192.
40. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., Hirai, H. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13, 3748-3756.
41. Scapoli, L., Ramos-Nino, M. E., Martinelli, M., Mossman, B. T. (2004) Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23, 805-813.
42. Shajahan, A. N., Tiruppathi, C., Smrcka, A. V., Malik, A. B., Minshall, R. D. (2004) Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells. J. Biol. Chem. 279, 48055-48062.
43. Shupnik, M. A. (2004) Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23, 7979-7989.
44. Silva, C. M. (2004) Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23, 8017-8023.
45. Sovová, V., Kučerová, D., Lišková, M., Šloncová, E., Tuháčková, Z. (1997) Changes in c-Src activity in a human colon cancer cell line during differentiation. Oncol. Rep. 4, 450-453.
46. Summy, J. M., Gallick, G. E. (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22, 337-358.
47. Svoboda, J. (2000) Cancer: is there involved a bunch of culprits, one culprit, or something in between? Folia Biol. (Praha) 46, 219-225.
48. Tuháčková, Z., Sovová, V., Šloncová, E., Proud, C. G. (1999) Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-src-transformed fibroblasts. Int. J. Cancer 81, 963-969.
49. Vojtěchová, M., Šloncová, E., Kučerová, D., Jiřička, J., Sovová, V., Tuháčková, Z. (2003) Initiation factor eIF2B not p70 S6 kinase involved in the activation of the PI-3K signalling pathway induced by the v-src oncogene. FEBS Lett. 43, 81-86.
50. Vojtěchová, M., Tuháčková, Z., Hlaváček, J., Velek, J., Sovová, V. (2004) The v-Src and c-Src tyrosine kinases immunoprecipitated from Rous sarcoma virus transformed cells display different peptide substrate specificities. Arch. Biochem. Biophys. 421, 277-282.
51. Waters, C. M., Connell, M. C., Pyne, S., Pyne, N. J. (2005) c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell. Signal. 17, 263-277.
52. Windham, T. C., Parikh, N. U., Siwak, D. R., Summy, J. M., McConkey, D. J., Kraker, A. J., Gallick, G. E. (2002) Src activation regulates anoikis in human colon tumor cell lines. Oncogene 21, 7797-7807.
53. Xu, B., Miller, W. T. (1996) Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain. Mol. Cell. Biochem. 158, 57-63.
54. Yeatman, T. J. (2004) A renaissance for SRC. Nat. Rev. Cancer 4, 470-480.